New Research Facility to Advance Genomics SeqOnce Biosciences, Inc., a genomics company creating new tools to detect and analyze human disease, is thrilled to announce it has officially completed their move into a new facility located in Carlsbad, CA. This move will significantly improve their research capabilities allowing them to expand the development of assay […]
Company Announces Initiation of Second Phase of Expansion Project LOVELAND, CO – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, further strengthens its commitment to the greater Loveland, Colorado community with the completion of the first phase of its new research and development hub. The grand opening of the new $10 […]
Aldevron, a global leader in the custom development and manufacture of plasmid DNA, RNA and proteins for the biotech industry, launches Eureca-Vâ„¢ Nuclease, the wild-type MAD7® CRISPR Type-V nuclease, licensed from Inscripta®, at Research Grade today with GMP to follow. Aldevron’s launch at Advanced Therapies Week of Eureca-V Nuclease expands the toolkit of available CRISPR […]
SAN DIEGO — BioBam launches the latest version of its bioinformatics software OmicsBox 3.0, with the new genetic variation module to be exhibited at the International Plant and Animal Genome Conference. BioBam will showcase its latest advancement at the largest AG-Genomics meeting in the world. The main highlight of OmicsBox version 3.0 is its new Genetic Variation […]
New company created to enable commercial manufacture of new cell and gene therapies Cellular Origins’ proprietary technology will address current barriers associated with cost-effective and efficient manufacture of cell and gene therapies at scale Cambridge, UK: TTP plc (TTP), a leading independent technology and product development company, has today announced the launch of Cellular Origins, a […]
Rapid advances in biotechnology in the last decade have revolutionized the life science industry. Genomics, for instance, are changing the game in terms of improving our understanding of living organisms, while driving the development of more targeted personalized medicines, therapies, and interventions around the globe. In Europe, the 1+ Million Genomes (1+MG) initiative recognizes the […]
SAN DIEGO — Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a collaboration with NVIDIA to develop an acceleration platform for use in Bionano’s optical genome mapping (OGM) workflow. This collaboration is expected to significantly improve data processing speed while reducing time and cost associated with secondary analysis of OGM data. The computation platform is designed […]
Munich, Germany — ibidi’s new Glass Bottom µ-Plates finally provide microscopists with outstanding, high-throughput possibilities for super-resolution and TIRF. When using the µ-Plate 96 Well or 384 Well Black Glass Bottom, the samples are observed through a thin #1.5H D 263 M Schott glass coverslip with a thickness of 170 µm +/- 5 µm. Due […]
New company advances precision health through data-driven solutions BOSTON & SAN FRANCISCO & STOCKHOLM — New company Velsera was announced today at the J.P. Morgan Healthcare Conference in San Francisco, California. The vision for Velsera is supported by thematic-focused impact fund Summa Equity (“Summa”). The promise of precision medicine is held back by barriers across routine health […]
New throughput-based model allows customers of all sizes to benefit from flexibility and lowest cost today SAN DIEGO, CA – Element Biosciences, Inc.— the developer of an innovative DNA sequencing platform disrupting genomics — announced a new throughput-based option for its AVITI System that provides the highest quality sequencing on a benchtop for as low as […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
